ArticleAnales del sistema sanitario de Navarra2025
[Triple synchronous primary lung adenocarcinoma: A diagnostic challenge].
Article in Anales del sistema sanitario de Navarra, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multiple primary lung cancer can be synchronous or metachronous based on the timing of lesion onset. Despite the existing classification criteria for lung cancer with multiple lung involvement, it is sometimes challenging to distinguish between lung cancer with multiple lung involvement and intrapulmonary metastases. Moreover, differentiating synchronous multiple primary lung cancer from multifocal ground-glass/lepidic-pattern lung cancer is crucial. While histologic evaluation can aid in diagnosis, molecular analyses are often necessary. We present the case of a female patient diagnosed with triple synchronous primary lung adenocarcinomas. Although the lesions shared the same histological subtype, they exhibited distinct histological patterns and molecular profiles. In cases of lung cancer with multiple lung involvement, it is essential to perform a detailed pathological study for an accurate diagnosis and appropriate therapeutic interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.